US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biologics: market research reports

A biologic medical product or a biologic or biological, is a medicinal product such as a vaccine, blood or blood component, gene therapy, tissue, recombinant therapeutic protein, or living cells that are used as therapeutics to treat diseases. Biologics are created by biologic processes, rather than being chemically synthesized. Biologics can be composed of sugars, proteins, or nucleic acids or a complex combination of these substances.
They may be living entities such as cells and tissues. Biologics are isolated from a variety of natural sources that can be human, animal, or microorganism.
RSS Feeds

Biologics market research reports and industry analysis

< prev 1    3  4  
Biologicals in Oncology: Drug Pathway Analyzer 2014
3/25/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 137 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 547 drug targets that are included ...  |  read more...
$9,187.50
Biologicals in Oncology Drug Pipeline Update 2014
3/25/2014 | published by: BioSeeker Group AB
... developing 1620 biological drugs in 3685 developmental projects in cancer. In addition, there are 28 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 920 drugs. Biologicals In ...  |  read more...
$9,372.50
Stakeholder Perspectives: Innovation within the Biopharma Industry
2/19/2014 | published by: FirstWord
... (NME) you have in research? Within the biopharma industry, R&D output is at odds with R&D investment. Between 1950 and 2010, the number of new molecules (including both biologics and small molecules) brought to market ...  |  read more...
$2,495.00
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325414
2/11/2014 | published by: Plunkett Research, Ltd.
... save countless hours of research. Core Benefits to Customer: 1) Comprehensive overview of an industry’s financial results, ratios, vital statistics and metrics in one package 2) Complete benchmarking of the industry and its top companies ...  |  read more...
$1,995.00
Lyophilisation for Pharmaceuticals: Products and Services 2014-2024
2/11/2014 | published by: Visiongain
... revenues to 2024, assessing data, trends, opportunities and prospects there. Our new study lets you assess projected sales at world market, submarket and national level to 2024. You will see financial results, interviews, trends, opportunities, ...  |  read more...
$2,788.00
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth
2/7/2014 | published by: GBI Research
... Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth”. The systemic psoriasis market is forecast to grow substantially over the forecast period from $5.0 billion in 2013 to ...  |  read more...
$3,500.00
Humira (Crohn’s Disease) - Forecast and Market Analysis to 2022
1/31/2014 | published by: GlobalData
... in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety and efficacy profiles translate to clinical ...  |  read more...
$3,495.00
Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need
1/31/2014 | published by: GBI Research
... Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need , which provides insights into three therapeutic indications in gastrointestinal disorders in Asia-Pacific (APAC) markets of ...  |  read more...
$3,500.00
Cimzia (Crohn’s Disease) - Forecast and Market Analysis to 2022
1/31/2014 | published by: GlobalData
... in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety and efficacy profiles translate to clinical ...  |  read more...
$3,495.00
Remicade (Crohn’s Disease) - Forecast and Market Analysis to 2022
1/31/2014 | published by: GlobalData
... in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety and efficacy profiles translate to clinical ...  |  read more...
$3,495.00
Tysabri (Crohn’s Disease) - Forecast and Market Analysis to 2022
1/31/2014 | published by: GlobalData
... in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety and efficacy profiles translate to clinical ...  |  read more...
$3,495.00
Prochymal (Crohn’s Disease) - Forecast and Market Analysis to 2022
1/31/2014 | published by: GlobalData
... in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety and efficacy profiles translate to clinical ...  |  read more...
$3,495.00
Entyvio (Crohn’s Disease) - Forecast and Market Analysis to 2022
1/31/2014 | published by: GlobalData
... in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety and efficacy profiles translate to clinical ...  |  read more...
$3,495.00
Stelara (Crohn’s Disease) - Forecast and Market Analysis to 2022
1/31/2014 | published by: GlobalData
... in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety and efficacy profiles translate to clinical ...  |  read more...
$3,495.00
Vercirnon (Crohn’s Disease) - Forecast and Market Analysis to 2022
1/31/2014 | published by: GlobalData
... in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety and efficacy profiles translate to clinical ...  |  read more...
$3,495.00
Analyzing the Biotechnology Industry in India
1/1/2014 | published by: Aruvian's R'search
... the country's biotech industry, the Indian biotechnology market has witnessed remarkable growth in recent years. The biotech industry in India did not bear the brunt of the recent economic recession and in fact due to ...  |  read more...
$500.00
Frontier Pharma: Systemic Lupus Erythematosus - Identifying and Commercializing First-in-Class Innovation
12/31/2013 | published by: GBI Research
... biologic, Benlysta (belimumab), generated sales of $111m in 2012, there is little evidence that the drug’s performance is significantly superior to other B-cell targeted therapies such as Rituxan (rituximab), which is often used off-license to ...  |  read more...
$3,500.00
Biotech API Manufacturing Services: World Industry and Market 2014-2024
12/12/2013 | published by: Visiongain
... you predictions of those revenues from 2014. There you see financial data, also assessing trends, technologies, clients' needs, and opportunities. That study gives you sales forecasts to 2024 at overall world market, submarket, and national ...  |  read more...
$2,788.00
Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)
11/1/2013 | published by: Daedal Research
... focus on biologics drugs. It also accesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period ...  |  read more...
$800.00
Bolus Injectors Market, 2014-2024
11/1/2013 | published by: Roots Analysis
... auto-injectors, the market has come a long way. Taking the concept of self-injectors to a new stratum, ‘Bolus Injectors’ have surfaced recently. Also known as non-insulin patch pumps, these devices not only offer a range ...  |  read more...
$1,699.00
Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth
10/18/2013 | published by: GBI Research
... Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth”. The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from ...  |  read more...
$3,500.00
The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry
10/16/2013 | published by: La Merie Publishing
... have become an increasingly successful treatment modality with sales of US$ 65 bln in the year 2012 and with an average (continuous) annual growth rate from 2006 to 2012 of 18.9%. While antibody technologies are ...  |  read more...
$1,919.00
Bispecific Antibody Therapeutics Market, 2013-2023
9/24/2013 | published by: Roots Analysis
... anti-CD3 antibody, Orthoclone Okt3, in 1986. A bispecific antibody is a second generation immunotherapy, an upgraded version of monoclonal antibody improved in structure and functionality. The conjugated artificial antibodies are formed by physically putting together ...  |  read more...
$1,699.00
Psoriasis Treatment: World Drug Market 2013-2023
9/5/2013 | published by: Visiongain
... 2013, helping you stay ahead. There you see financial results, R&D trends, opportunities, and potential revenues. Avoid falling behind, then, missing business or losing influence. In our new report you see forecasted sales to 2023 ...  |  read more...
$2,633.00
Biological and Biological Product Manufacturing in China
9/2/2013 | published by: IBISWorld
... the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their ...  |  read more...
$1,020.00
< prev 1    3  4  
 
Our Clients